Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Gross Profit: 2020-2022

Historic Gross Profit for Immuneering (IMRX) over the last 3 years, with Dec 2022 value amounting to $158,830.

  • Immuneering's Gross Profit rose 102.74% to $455 in Q4 2022 from the same period last year, while for Dec 2022 it was $158,830, marking a year-over-year decrease of 82.86%. This contributed to the annual value of $158,830 for FY2022, which is 82.86% down from last year.
  • Latest data reveals that Immuneering reported Gross Profit of $158,830 as of FY2022, which was down 82.86% from $926,888 recorded in FY2021.
  • Immuneering's 5-year Gross Profit high stood at $1.0 million for FY2020, and its period low was $158,830 during FY2022.
  • Its 3-year average for Gross Profit is $705,643, with a median of $926,888 in 2021.
  • Data for Immuneering's Gross Profit shows a maximum YoY slumped of 82.86% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows Immuneering's Gross Profit stood at $1.0 million in 2020, then declined by 10.12% to $926,888 in 2021, then tumbled by 82.86% to $158,830 in 2022.